triaziquone has been researched along with Thyroid Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunat, M; Dargent, M; Mayer, H; Pommatau, E | 1 |
| Butzler, W; Hartwich, G | 1 |
2 other study(ies) available for triaziquone and Thyroid Neoplasms
| Article | Year |
|---|---|
Complete regression of metastatic tumors of the adult with antimitotic treatment.
Topics: Adolescent; Adult; Antineoplastic Agents; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Female; Follow-Up Studies; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Infant; Lung Neoplasms; Male; Mechlorethamine; Mercaptopurine; Methotrexate; Middle Aged; Neoplasm Metastasis; Pregnancy; Prostatic Neoplasms; Sarcoma; Teratoma; Testicular Neoplasms; Thoracic Neoplasms; Thyroid Neoplasms; Triaziquone; Uterine Neoplasms; Vinblastine | 1974 |
[Secondary tumors in hemoblastoses during cytostatic treatment].
Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Agents; Bronchial Neoplasms; Busulfan; Carcinoma; Chlorambucil; Cyclophosphamide; Dysgerminoma; Female; Gallbladder Neoplasms; Hemangioma, Cavernous; Hodgkin Disease; Humans; Kidney Neoplasms; Laryngeal Neoplasms; Leukemia; Lipoma; Liver Neoplasms; Lymphatic Diseases; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Neuroma; Ovarian Neoplasms; Papilloma; Plasmacytoma; Rectal Neoplasms; Statistics as Topic; Teratoma; Thyroid Neoplasms; Triaziquone; Urethane; Waldenstrom Macroglobulinemia | 1971 |